Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortBackbone drug for HIV treatment, PrEP and hepatitis B.Core of the WHO-preferred HIV treatment.
Body systemAntiviralsAntivirals
Drug classNucleos(t)ide reverse transcriptase inhibitorsIntegrase inhibitors
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesHIV treatment, HIV pre-exposure prophylaxis (PrEP, with emtricitabine), Chronic hepatitis BHIV-1 treatment (with other antiretrovirals)
How it worksA fake DNA building block that stops HIV and hepatitis B copying themselves.Stops HIV inserting its genes into your cells' DNA.
Starts working——
Half-lifeAbout 17 hours in plasmaAbout 14 hours
Typical adult dose300 mg (245 mg tenofovir disoproxil) once a day.50 mg once a day (twice a day with rifampicin or certain resistance).
FormsTablet, Combination tabletsTablet, Dispersible tablet, Combination tablets (TLD, Triumeq, Dovato)
Common side effectsNausea, Diarrhoea, Headache, DizzinessHeadache, Insomnia, Weight gain, Nausea
Serious side effectsKidney damage, Bone thinning, Hepatitis B flare if stopped suddenlyHypersensitivity reaction (rare), Liver injury in hepatitis co-infection, Depression (rare)
Don't take if——
Alcohol——
PregnancyGenerally considered safeWidely used in pregnancy for HIV and hepatitis B.Generally considered safeAn early signal of neural tube defects shrank with more data; WHO recommends it for all, including in pregnancy.
Breastfeeding——
In use since20012013
Brand namesUnited States: Viread, Truvada (with emtricitabine)United Kingdom: Viread, TruvadaIndia: TenvirUnited States: TivicayUnited Kingdom: TivicayAustralia: Tivicay
Legal status——
ATC codeJ05AF07J05AJ03

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker